ENOB News and Press, Enochian Biosciences Inc. From 06/01/22

NEW YORK, NY / ACCESSWIRE / June 1, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Enochian Biosciences, Inc. ("Enochian" or the "Company") (NASDAQ:ENOB). If you suffered losses exceeding $50,000 investing in Enochian stoc...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: motorolka / Shutterstock.com ENOB stock is plummeting more than 30% today after Hindenburg Research released a short report on the company. Enochian Biosciences’ co-founder and largest shareholder, Serh...

Gainers: Tonix Pharmaceuticals Holding (TNXP) +60%. Helius Medical Technologies (HSDT) +40%. View (VIEW) +42%. Spark Networks (LOV) +32%. Regencell Bioscience Holdings (RGC) +21%. 180 Life Sciences (ATNF) +20%. Evelo Biosciences (EVLO) +17%. NeuroOne Medical Technologies Corporation (NMTC) +1...

Gainers: Helius Medical Technologies (HSDT) +57%. Tonix Pharmaceuticals  TNXP +49%. NeuroOne Medical Technologies (NMTC) +16%. Oncternal Therapeutics (ONCT) +16%. Butterfly Network (BFLY) +15%. Losers: Enochian Biosciences ENOB -37%. Icosavax ...

Enochian Biosciences (NASDAQ:ENOB) plummeted 25% after Hindenburg Research released a full short report on the company after it teased one last week after the company's co-founder was arrested in an alleged murder-for-hire plot. Enochian Biosciences’ co-founder and largest shareho...

LOS ANGELES, May 31, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) - Enochian BioSciences is working to solve our greatest public health threats like HIV, cancer, and coronavirus. The company’s underlying scientific ideas are innovative with an elegant simplicity, characteristics that are ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ulta Beauty (NASDAQ: ULTA ) stock is jumping on a strong earnings report. This saw it beat out diluted EPS and revenue estimates. The cosmetics company also increased its outlook for 2022. Source: Ryan P Ste...

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Enochian Biosciences, Inc. (“Enochian” or the “Company”) (NASDAQ: ENOB) on behalf of Enochian stockholders. Our investigation conce...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Enochian Biosciences (NASDAQ: ENOB ) stock gained 20% today despite the arrest of founder Serhat Gumrukcu. Gumrukcu was arrested on Tuesday in a murder-for-hire conspiracy. According to a De...

Gainers: Apyx Medical (APYX) +39%. Enochian Biosciences (ENOB) +17%. Concert Pharmaceuticals (CNCE) +14%. GeoVax Labs (GOVX) +14%. Liquidia (LQDA) +13%. Losers: NRx Pharmaceuticals (NRXP) -57%. Avadel Pharmaceuticals (AVDL) -44%. Nurix Therape...